Lantheus Holdings Inc
Drug Manufacturers - Specialty & Generic
Healthcare
LNTH
71.46 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
50.62
52 week high
116.69
high
52.81
52 week low
0.00
low
50.62
growth
-52.69 %
previous Close
50.11
P/E ratio
market cap
5.00 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
-19.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top